GPR109 receptor agonist-1（Cat No.:I007240）is a synthetic compound designed to activate the GPR109A receptor, a G-protein-coupled receptor primarily expressed in immune cells, adipocytes, and the gastrointestinal tract. This receptor is involved in regulating processes like inflammation, lipid metabolism, and glucose homeostasis. Activation of GPR109A has been shown to exhibit anti-inflammatory effects and may help in the treatment of conditions such as metabolic disorders, inflammatory diseases, and possibly atherosclerosis. GPR109 receptor agonist-1 is under investigation for its potential to modulate these pathways, offering therapeutic benefits in managing metabolic and inflammatory diseases.